Group 2 Pulmonary Hypertension: Pulmonary Venous Hypertension: Epidemiology and Pathophysiology

被引:15
|
作者
Clark, Craig B. [1 ]
Horn, Evelyn M. [2 ]
机构
[1] Des Moines Univ, Div Cardiol, Dept Internal Med, Iowa Heart Ctr, Des Moines, IA 50312 USA
[2] Weill Cornell Med Ctr, Div Cardiol, Perkin Heart Failure Ctr, 520 East 70th St,Starr Pavilion,4th Floor, New York, NY 10021 USA
关键词
Pulmonary hypertension; Left heart disease; Valvular disease; Epidemiology; Pathophysiology; PRESERVED EJECTION FRACTION; LEFT-HEART DISEASE; RIGHT-VENTRICULAR DYSFUNCTION; FIBROTIC ATRIAL CARDIOMYOPATHY; ARTERY PRESSURE; PHOSPHODIESTERASE-5; INHIBITION; NATRIURETIC PEPTIDE; SYSTOLIC PRESSURE; CARDIAC FIBROSIS; AORTIC-STENOSIS;
D O I
10.1016/j.ccl.2016.04.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary hypertension from left heart disease (PH-LHD) is the most common form of PH, defined as mean pulmonary artery pressure >= 25 mm Hg and pulmonary artery wedge pressure >= 15 mm Hg. PH-LHD development is associated with more severe left-sided disease and its presence portends a poor prognosis, particularly once right ventricular failure develops. Treatment remains focused on the underlying LHD and despite initial enthusiasm for PH-specific therapies, most studies have been disappointing and their routine clinical use cannot be recommended. More work is urgently needed to better understand the pathophysiology underlying this disease and to develop effective therapeutic strategies.
引用
收藏
页码:401 / +
页数:12
相关论文
共 50 条
  • [41] Pathophysiology of Group 3 Pulmonary Hypertension Associated with Lung Diseases and/or Hypoxia
    Nakamura, Kazufumi
    Akagi, Satoshi
    Ejiri, Kentaro
    Taya, Satoshi
    Saito, Yukihiro
    Kuroda, Kazuhiro
    Takaya, Yoichi
    Toh, Norihisa
    Nakayama, Rie
    Katanosaka, Yuki
    Yuasa, Shinsuke
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (02)
  • [42] Effect of Group 2 Pulmonary Hypertension Subgroups on Outcomes: Impact of the Updated Definition of Pulmonary Hypertension
    Bayram, Zubeyde
    Dogan, Cem
    Efe, Suleyman Cagan
    Karagoz, Ali
    Guvendi, Busra
    Uysal, Samet
    Aktas, Ravza Betul
    Akbal, Ozgur Yasar
    Yilmaz, Fatih
    Tokgoz, Hacer Ceren
    Kirali, Mehmet Kaan
    Kaymaz, Cihangir
    Ozdemir, Nihal
    HEART LUNG AND CIRCULATION, 2022, 31 (04): : 508 - 519
  • [43] Pulmonary hypertension and right ventricular dysfunction in left heart disease (group 2 pulmonary hypertension)
    Wilson, Sean R.
    Ghio, Stefano
    Scelsi, Laura
    Horn, Evelyn M.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2012, 55 (02) : 104 - 118
  • [44] RESPONSE OF PULMONARY CIRCULATION TO CHRONIC PULMONARY VENOUS HYPERTENSION
    HOPKINS, RA
    HAMMON, JW
    SMITH, PK
    MCHALE, PA
    ANDERSON, RW
    CIRCULATION, 1978, 58 (04) : 81 - 81
  • [45] Partial Anomalous Pulmonary Venous Connection With Pulmonary Hypertension
    Hernandez Vazquez, Julio
    de Miguel Diez, Javier
    de Cortina Camarero, Cristina
    ARCHIVOS DE BRONCONEUMOLOGIA, 2015, 51 (03): : 153 - 154
  • [46] Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update
    Noordegraaf, Anton Vonk
    Chin, Kelly Marie
    Haddad, Francois
    Hassoun, Paul M.
    Hemnes, Anna R.
    Hopkins, Susan Roberta
    Kawut, Steven Mark
    Langleben, David
    Lumens, Joost
    Naeije, Robert
    EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (01)
  • [47] The Impact of Pulmonary Venous Hypertension on the Pulmonary Circulation in the Young
    Kulik, Thomas J.
    Harris, Julia E.
    McElhinney, Doff B.
    CONGENITAL HEART DISEASE, 2011, 6 (06) : 603 - 607
  • [48] The Biological Bases of Group 2 Pulmonary Hypertension
    Fernandez, Ana I.
    Yotti, Raquel
    Gonzalez-Mansilla, Ana
    Mombiela, Teresa
    Gutierrez-Ibanes, Enrique
    Perez del Villar, Candelas
    Navas-Tejedor, Paula
    Chazo, Christian
    Martinez-Legazpi, Pablo
    Fernandez-Aviles, Francisco
    Bermejo, Javier
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (23)
  • [49] Group 2 Pulmonary Hypertension Special Issue
    Guazzi, Marco
    Park, Myung H.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2016, 59 (01) : 1 - 2
  • [50] The Diagnostic Challenge of Group 2 Pulmonary Hypertension
    Naeije, Robert
    D'Alto, Michele
    PROGRESS IN CARDIOVASCULAR DISEASES, 2016, 59 (01) : 22 - 29